Mirae Asset Global Etfs Holdings Ltd. Artivion, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Artivion, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 20,890 shares of AORT stock, worth $857,534. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,890
Previous 23,591
11.45%
Holding current value
$857,534
Previous $579,000
12.09%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AORT
# of Institutions
193Shares Held
40.1MCall Options Held
19.2KPut Options Held
0-
Black Rock Inc. New York, NY6.64MShares$272 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.96MShares$121 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$115 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$115 Million3.82% of portfolio
-
Morgan Stanley New York, NY2.32MShares$95.2 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.65B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...